ArticleJournal of neurology2026
SCA27B in Brazil: frequency, phenotype and genotype-phenotype correlations.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundSpinocerebellar Ataxia 27B (SCA27B) is a recently described autosomal dominant ataxia caused by uniallelic GAA intronic expansions at FGF14. It is a frequent SCA subtype in North American/European populations, accounting for > 20% of all SCAs in some series. Despite that, its frequency as well as phenotype in Latin America remains to be established.
objectivesTo determine the frequency and the clinical phenotype of SCA27B in a large Brazilian SCA cohort.
methodsWe recruited 498 SCA patients from 322 unrelated families followed in a reference center. All patients had demographic and clinical data collected. The estimated disease progression rate was computed as the ratio between the Scale for the Assessment and Rating of Ataxia (SARA) score and disease duration (in years). Genetic testing included long-range and triplet-primed PCR-based approaches to diagnose SCA1, 2, 3, 6, 7 and SCA27B.
resultsSCA27B was identified in 9 out of the 322 index-patients, totaling 2.8% of all cases. It stands as the fifth most common SCA, surpassed by SCAs 3, 1, 2, and 7, respectively. The typical phenotype in our cases was similar to previous descriptions: late onset (mean age 55.5 years), slow progression (1.0 points/year) and relatively pure ataxic phenotype (11/12). In this cohort, the estimated disease progression rate did correlate with age at onset, but not with (GAA)n. DISCUSSION: SCA27B is a prevalent SCA in Brazil, but the relative frequency seems to be smaller than in Europe/Canada. It should be included in SCA routine diagnostic protocols. Age at onset might be a potential prognostic marker in this condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.